Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection.
- Published in:
- Medical Journal of Viral Hepatitis, 2024, v. 8, n. 1, p. 9, doi. 10.21608/mjvh.2024.350727
- By:
- Publication type:
- Article
Works matching IS 23148748 AND DT 2024 AND VI 8 AND IP 1
Results: 3
1
2
Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ?
- Published in:
- Medical Journal of Viral Hepatitis, 2024, v. 8, n. 1, p. 17, doi. 10.21608/mjvh.2024.350728
- By:
- Publication type:
- Article
3
Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis.
- Published in:
- Medical Journal of Viral Hepatitis, 2024, v. 8, n. 1, p. 1, doi. 10.21608/mjvh.2024.350725
- By:
- Publication type:
- Article